-+ 0.00%
-+ 0.00%
-+ 0.00%

ENTRADA THERAPEUTICS RECEIVES AUTHORIZATION IN THE EUROPEAN UNION TO INITIATE ELEVATE-45-201, A PHASE 1/2 MULTIPLE ASCENDING DOSE CLINICAL STUDY OF ENTR-601-45 IN PATIENTS LIVING WITH DUCHENNE MUSCULAR DYSTROPHY AMENABLE TO EXON 45 SKIPPING

Reuters·05/28/2025 11:00:01

Please log in to view news